BIRC5 and osteosarcoma: Additionally, the survivin gene can be employed as a biomarker for the prognosis of osteosarcoma, abating the shortage that prognosis is mainly determined by the merely assistant prognostic parameters concerning chemotherapy, tumor size and surgical margin width [5].